1. Home
  2. TSBX vs SHFS Comparison

TSBX vs SHFS Comparison

Compare TSBX & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • SHFS
  • Stock Information
  • Founded
  • TSBX 2015
  • SHFS 2015
  • Country
  • TSBX United States
  • SHFS United States
  • Employees
  • TSBX N/A
  • SHFS N/A
  • Industry
  • TSBX
  • SHFS Finance: Consumer Services
  • Sector
  • TSBX
  • SHFS Finance
  • Exchange
  • TSBX Nasdaq
  • SHFS Nasdaq
  • Market Cap
  • TSBX 7.7M
  • SHFS 6.3M
  • IPO Year
  • TSBX 2023
  • SHFS N/A
  • Fundamental
  • Price
  • TSBX $0.36
  • SHFS $3.83
  • Analyst Decision
  • TSBX Buy
  • SHFS
  • Analyst Count
  • TSBX 3
  • SHFS 0
  • Target Price
  • TSBX $4.75
  • SHFS N/A
  • AVG Volume (30 Days)
  • TSBX 471.7K
  • SHFS 40.8K
  • Earning Date
  • TSBX 08-13-2025
  • SHFS 08-13-2025
  • Dividend Yield
  • TSBX N/A
  • SHFS N/A
  • EPS Growth
  • TSBX N/A
  • SHFS N/A
  • EPS
  • TSBX N/A
  • SHFS N/A
  • Revenue
  • TSBX N/A
  • SHFS $13,956,453.00
  • Revenue This Year
  • TSBX N/A
  • SHFS N/A
  • Revenue Next Year
  • TSBX N/A
  • SHFS N/A
  • P/E Ratio
  • TSBX N/A
  • SHFS N/A
  • Revenue Growth
  • TSBX N/A
  • SHFS N/A
  • 52 Week Low
  • TSBX $0.29
  • SHFS $1.84
  • 52 Week High
  • TSBX $2.65
  • SHFS $14.60
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 53.01
  • SHFS 64.28
  • Support Level
  • TSBX $0.33
  • SHFS $3.40
  • Resistance Level
  • TSBX $0.37
  • SHFS $3.89
  • Average True Range (ATR)
  • TSBX 0.01
  • SHFS 0.41
  • MACD
  • TSBX -0.00
  • SHFS 0.13
  • Stochastic Oscillator
  • TSBX 74.50
  • SHFS 77.14

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.

Share on Social Networks: